Background: Preclinical data suggest that metformin may reduce breast cancer incidence
and improve cancer prognosis. However, the current evidence in observational studies is …

Based on own translational research of the biochemical and hormonal effects of cow's milk
consumption in humans, this review presents milk as a signaling system of mammalian …

Type II diabetes is associated with poor breast cancer prognosis. To study the association
between a diabetes risk reduction diet (DRRD) and survival following breast cancer, we …

Background This study investigated the effects of metformin and weight loss on biomarkers
associated with breast cancer prognosis. Methods Overweight/obese postmenopausal …

Background Diabetes has been associated with increased risk of cancer, including breast
cancer and colorectal cancer. Metformin, an oral hypoglycemic drug, but not other anti …

Background The activation of insulin pathways is hypothesized to promote tumor growth and
worsen breast cancer survival. Sugar‐sweetened beverages (SSBs) can lead to a higher …

The widely prescribed diabetes medicine metformin has been reported to lower the risk of
incident breast cancer, but it is unclear whether it affects malignant progression after …

Background: We investigated the associations of postdiagnostic dietary glycemic index (GI),
glycemic load (GL), insulin index (II), and insulin load (IL) with breast cancer–specific and all …

Objective Comorbidity among breast cancer survivors is prevalent, and adherence to
medication management of comorbidities may be important for both chronic disease and …

Purpose: Many patients with breast cancer are treated for other conditions and experience
polypharmacy with multiple concurrent medications. Our aim was to evaluate polypharmacy …